Clinically-formulated dermal filler containing 20mg/ml medical-grade hyaluronic acid with 0.3% lidocaine. Features uniform HA particles (98% purity) for natural volumizing effects lasting 6-9 months. FDA-cleared manufacturing process with <2.0 EU/ml endotoxin levels ensures optimal safety profile for mid-to-deep dermal correction.

△ Key Clinical Advantages

△ Advanced Delivery System

△ Professional Protocol

*Individual results may vary based on skin type, age, and injection technique. Clinical data shows 12-15% variation in duration between patients. Not for self-administration – must be administered by licensed medical professionals only. Product efficacy validated in 2022 clinical trial (n=142).

Manufactured by Genoss Co., Ltd. (KFDA License: 329087-2020). Storage: 2-25°C. Batch tracking available. Packaging: 1×1ml syringe + 2×27G needles. Expiry: 24 months from manufacture date.